Please assess the completion status of the following clinical trial:

Trial Title: Comparison of CornerLoc SI Joint Stabilization and Steroid Injections for Sacroiliac Joint Dysfunction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects meeting all of the following inclusion criteria by the end of the screening phase should be considered for admission to the study:~  * Subject must provide written informed consent prior to any clinical study-related procedure.~ * Subject is at least 18 years (or the minimum age required by local law to consent for participation in a clinical investigation) or older at the time of enrollment.~ * Subjects must meet criteria for sacroiliac joint dysfunction as determined below:~ * History of persistent pain in the distribution of the sacroiliac joint despite adequate trial of physical therapy.~ * NRS for pain ≥ 7 on a 0 -.10-point scale.~ * 3 of 5 provocative tests with positive findings on physical examination (SI distraction, thigh thrust, FABER, lateral compression, Gaenslen's maneuver).~ * Positive response (≥75% percent pain relief) to diagnostic sacroiliac joint injection on two occasions at least one week apart.~ * Baseline pain with 30-day history and PROMIS-29~Exclusion Criteria:~* Patient will not be entered into the study if they meet one of the following criteria:~  * Subject is unable to provide written informed consent~ * Subject is enrolled, or intends to participate, in a clinical drug and/or device study (investigational device, investigational drug, new indication for a device or drug, or additional testing beyond standard of care procedures) which could confound the results of this trial as determined by the investigator.~ * Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results.~ * Subject had prior surgical fusion implanted on same side~ * Subject is pregnant or nursing~ * Self-reported plan to bear children~ * BMI ≥ 40~ * DEXA \< -2.5 (if available)~ * History of microfractures~ * History of compression fractures~ * History of diabetes, must have A1c \<8~ * History of chronic steroid use~ * Chronic immunosuppression

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CornerLoc SI Joint Stabilization Group (Type: ACTIVE_COMPARATOR): Patient will receive the CornerLoc minimally invasive SI Joint Stabilization procedure. This procedure will be performed in an outpatient surgery center under local sedation or general anesthesia, and normally takes around 45 minutes. During the procedure, the physician will make two small incisions in the patient's lower back to access the SI joint, and place four small cadaveric bone grafts into the SI joint to help stabilize the SI joint.
- SI Joint Steroid Injections Group (Type: ACTIVE_COMPARATOR): Patient will receive an injection of steroid medication directly into their SI joint. The area around the SI joint will be numbed with an injection of local anesthetic and then ultrasound guidance will be used to guide the needle of steroid medication directly into the SI joint. This procedure will be performed in the physician's office or an outpatient surgery center, and normally takes around 30 minutes.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues